Publications
Confronting the growing epidemic of silicosis and tuberculosis among small-scale miners
An estimated 49·5 million small-scale miners worldwide are exposed to high concentrations of silica during their work. The substantial morbidity and mortality of silicosis and tuberculosis among workers exposed to such intensities have been documented. This Viewpoint raises concern at the failure to respond to a growing epidemic of lung disease (predominantly silicosis and tuberculosis) among small-scale miners.
Assessment of cancer biomarkers in the Grenfell firefighter cohort study
Occupational lung disease: what the general physician needs to know
Occupational exposures are a common and preventable cause of lung disease. About one in six cases of chronic obstructive pulmonary disease (COPD) and asthma worldwide are related to work.
Mortality risk associated with occupational exposures in people with small airways obstruction
Background
Small airways obstruction (SAO) has been associated with occupational exposures. Whether exposure to harmful occupational agents impacts the survival of people with SAO is unknown. Our aim was to estimate the mortality risk associated with occupational exposures among people with SAO.
Methods
Small airways obstruction and mortality: findings from the UK Biobank
Background
Small airways obstruction (SAO) is common in general populations. It has been associated with respiratory symptoms, cardiometabolic diseases, and progression to COPD over time. Whether SAO predicts mortality is largely unknown.
Research Question
Is spirometry-defined SAO associated with increased mortality?
Methods
Occupational exposure to particulate matter and staff sickness absence on the London underground
The London Underground (LU) employs over 19,000 staff, some of whom are exposed to elevated concentrations of particulate matter (PM) within the network. This study quantified the occupational exposure of LU staff to subway PM and investigated the possible association with sickness absence (SA).
A job exposure matrix to quantify subway PM2.5 staff exposure was developed by undertaking measurement campaigns across the LU network. The association between exposure and SA was evaluated using zero-inflated mixed-effects negative binomial models.
Scoping review of exposure questionnaires and surveys in interstitial lung disease
Background Many interstitial lung diseases (ILDs) have clear causal relationships with environmental and occupational exposures. Exposure identification can assist with diagnosis, understanding disease pathogenesis, prognostication and prevention of disease progression and occurrence in others at risk. Despite the importance of exposure identification in ILD, there is no standardised assessment approach. Many questionnaires are in clinical and research use, yet their utility, applicability, relevance and performance characteristics are unknown.
Artificial stone silicosis: A UK case series
Silicosis due to artificial stone (AS) has emerged over the last decade as an increasing global issue. We report the first eight UK cases. All were men; median age was 34 years (range 27–56) and median stone dust exposure was 12.5 years (range 4–40) but in 4 cases was 4–8 years. One is deceased; two were referred for lung transplant assessment. All cases were dry cutting and polishing AS worktops with inadequate safety measures. Clinical features of silicosis can closely mimic sarcoidosis.
Relationship between cumulative silica exposure and silicosis: a systematic review and dose-response meta-analysis
A call to invest in post-TB lung disease to halt TB transmission in communities
Dear Editor We undertook an evaluation of former TB patients for pulmonary rehabilitation. Our diagnostic evaluation aimed to implement clinical standards for post-TB lung disease (PTLD) using operational research. 1 Nightingale et al. also issued a clinical statement, addressing diverse post-TB morbidities such as social, economic, neurological, cardiovascular, PTLD and psychiatric impairments. 2 In low-and middle-income African countries (such as Sudan, Ethiopia and Kenya), only 4 in 10 clinicians can diagnose PTLD, contributing to an underestimation of its burden.
